Health Innovations
VC Fund
Utrecht, The Netherlands
Health Innovations is a VC fund in Utrecht focused on Health Care and Medical. Health Innovations invests in young companies that make healthcare better and more affordable. They focus on innovative care concepts, eHealth, medical technology, Digital Health and Health Services. The market is central to their process. How companies can contribute to improving healthcare processes: prevention, diagnosis, treatment andmonitoring. They invest in the Seed and Growth stage, and their investment must contribute to value creation for healthcare, the entrepreneurs and the shareholders. They play an active role as a shareholder by deploying their knowledge, experience and network but do not take on the role of the entrepreneur.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Health Innovations invests in
Stages Health Innovations invests in
Countries Health Innovations invests in
Investment Focus
Industry
- Health Care 6 (67%)
- Medical 4 (44%)
- Medical Device 4 (44%)
- Hospital 2 (22%)
- Therapeutics 2 (22%)
Stage
- Seed 3 (33%)
- Venture - Series Unknown 2 (22%)
- Series A 1 (11%)
- Series C 1 (11%)
- Series D 1 (11%)
Country
- The Netherlands 5 (56%)
- United States 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aiosyn
|
Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancerand CKD drug development studies for biopharma. | $2.8M / Seed / Sep 09, 2025 | |
ViCentra
|
ViCentra, they like to keep things simple.ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things.Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customerexperiences.From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people. | $85M / Series D / Sep 03, 2025 | |
|
Aiosyn
|
Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancerand CKD drug development studies for biopharma. | $2.1M / Seed / Dec 21, 2022 | |
Prolira makers of DeltaScan®
|
Prolira is committed to enabling early and effective treatment of acute encephalopathy and delirium. Every year, 20 million patients are at risk of acute brain failure in EU and US hospitals, which leads to long-term cognitive impairment, extended hospital stays, and increased healthcare costs.Prolira’s DeltaScan® Brain State Monitor is theworld’s first EEG bedside device with a validated proprietary algorithm to support clinicians in their quest to optimize patient recovery. | $4.4M / Venture - Series Unknown / Feb 01, 2022 | |
Bilihome B.V.
|
Bilihome aims to provide an ordinary-looking romper or vest for newborns, which enables natural care and free bonding during jaundice therapy in the first week of life. The embedded smart wearables and the miniaturized system simplify the logistics and encourage care outside the hospital. | Seed / Jan 23, 2022 | |
|
ViCentra
|
ViCentra, they like to keep things simple.ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things.Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customerexperiences.From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people. | $73.7M / Series C / Dec 16, 2021 | |
|
ViCentra
|
ViCentra, they like to keep things simple.ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things.Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customerexperiences.From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people. | $11.3M / Venture - Series Unknown / Jul 08, 2020 | |
Shleep
|
Shleep is an app-based sleep coaching platform in the Health Tech sector, that enables people and organizations reap the benefits of better sleep. A unique algorithm ensures that users receive tailormade sleep advice based on their specific situation. Though the platform revolves around the app, Shleep also offers online sleep assessments, liveworkshops, online webinars, and personal coaching. Several large companies have agreed to be our pilot customers and test our product and services. | $1.5M / Seed / Aug 20, 2019 | |
DEARhealth
|
DEARhealth offers Value-based Health Care solutions for medical providers and health insurers, which significantly improve the health outcomes and experience of chronically ill patients while dramatically reducing costs. | $6.8M / Series A / Jul 17, 2019 |
Co-Investors
OostNL
4 deals together
EQT Life Sciences
3 deals together
Inkef
2 deals together
Invest-NL
2 deals together
LUMO labs
2 deals together
Partners in Equity
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Health Innovations invest in?
Health Innovations invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Venture - Series Unknown stage. Most of the 9 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Health Innovations last invest?
The most recent investment recorded for Health Innovations closed in Sep 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
